1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Irritable Bowel Syndrome with Constipation Drugs Market
2.2. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Drug Type, 2021 (US$ Million)
2.3. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Prescription type, 2021 (US$ Million)
2.4. Global Irritable Bowel Syndrome with Constipation Drugs Market, By Geography, 2021 (US$ Million)
2.5. Impact of Covid 19
2.6. Attractive Investment Proposition by Geography, 2021
2.7. Competitive Analysis
2.7.1. Market Positioning of Key Irritable Bowel Syndrome with Constipation Drugs Market Vendors
2.7.2. Strategies Adopted by Irritable Bowel Syndrome with Constipation Drugs Market Vendors
2.7.3. Key Industry Strategies
2.7.4. Tier Analysis 2021 Versus 2030
2.8. Key Buying Criteria
2.9. Key Case Reports
2.10. Scenario Analysis
2.10.1. Optimistic estimates and analysis
2.10.2. Realistic estimates and analysis
2.10.3. Pessimistic estimates and analysis
2.11. Market Profiling
2.12. Sales and Marketing Plan
2.13. Top Market Conclusions
2.14. Strategic Recommendations
3. Irritable Bowel Syndrome with Constipation Drugs Market: Business Outlook & Market Dynamics
3.1. Introduction
3.2. Global Irritable Bowel Syndrome with Constipation Drugs Market Value, 2020 - 2030, (US$ Million)
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.2. Market Restraints
3.3.3. Key Challenges
3.3.4. Key Opportunities
3.4. Impact Analysis of Drivers and Restraints
3.5. See-Saw Analysis
3.6. Porter’s Five Force Model
3.6.1. Supplier Power
3.6.2. Buyer Power
3.6.3. Threat Of Substitutes
3.6.4. Threat Of New Entrants
3.6.5. Competitive Rivalry
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technology Landscape
3.7.4. Legal Landscape
3.7.5. Social Landscape
3.8. Heptalysis Analysis
3.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions
4. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
4.1. Market Overview
4.2. Growth & Revenue Analysis: 2021 Versus 2030
4.3. Market Segmentation
4.3.1. Lubiprostone
4.3.2. Linaclotide
4.3.3. Stimulant Laxatives - Bisacodyl
4.3.4. Osmotic Laxatives
4.3.5. Lactulose
4.3.6. Polyethylene Glycol
5. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Prescribed
5.3.2. Over the Counter Type (OTC)
6. North America Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
6.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
6.4.1. North America
6.4.1.1. U.S.
6.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
6.4.1.2. Canada
6.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
6.4.1.3. Rest of North America
6.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
6.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7. UK and European Union Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
7.4.1. UK and European Union
7.4.1.1. UK
7.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.2. Germany
7.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.3. Spain
7.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.4. Italy
7.4.1.4.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.4.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.5. France
7.4.1.5.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.5.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
7.4.1.6. Rest of Europe
7.4.1.6.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
7.4.1.6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
8.4.1. Asia Pacific
8.4.1.1. China
8.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.2. Japan
8.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.3. India
8.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.4. Australia
8.4.1.4.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.4.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.5. South Korea
8.4.1.5.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.5.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
8.4.1.6. Rest of Asia Pacific
8.4.1.6.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
8.4.1.6.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9. Latin America Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
9.4.1. Latin America
9.4.1.1. Brazil
9.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9.4.1.2. Mexico
9.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
9.4.1.3. Rest of Latin America
9.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
9.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10. Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.3. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10.4. Irritable Bowel Syndrome with Constipation Drugs Market: By Region, 2020-2030, USD (Million)
10.4.1. Middle East and Africa
10.4.1.1. GCC
10.4.1.1.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.1.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10.4.1.2. Africa
10.4.1.2.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.2.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
10.4.1.3. Rest of Middle East and Africa
10.4.1.3.1. Irritable Bowel Syndrome with Constipation Drugs Market: By Drug Type, 2020-2030, USD (Million)
10.4.1.3.2. Irritable Bowel Syndrome with Constipation Drugs Market: By Prescription type, 2020-2030, USD (Million)
11. Company Profile
11.1. Abbott Laboratories, Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Ardelyx, Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Astellas Pharma Inc.
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. AstraZeneca Plc.
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Bayer AG
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Fresenius Kabi AG
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. Ironwood Pharmaceuticals, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Sanofi S.A.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. SK Biopharmaceuticals Co., Ltd.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Sucampo AG
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. Synergy Pharmaceuticals, Inc.
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Synthetic Biologics, Inc.
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives
List of Figures
Figure 1 Global Irritable Bowel Syndrome with Constipation Drugs Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Irritable Bowel Syndrome with Constipation Drugs Market: Quality Assurance
Figure 5 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Drug Type, 2021
Figure 6 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Prescription type, 2021
Figure 7 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Irritable Bowel Syndrome with Constipation Drugs Market, 2021
Figure 9 Market Positioning of Key Irritable Bowel Syndrome with Constipation Drugs Market Players, 2021
Figure 10 Global Irritable Bowel Syndrome with Constipation Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Porters Five Force Model - Current, Midterm and Long Term Perspective
Figure 12 See Saw Analysis
Figure 13 PETEL Analysis
Figure 14 Key Buying Criteria: Current and Long-Term Perspective
Figure 15 Global Irritable Bowel Syndrome with Constipation Drugs Market, Scenario Analysis, 2020 to 2030 (US$ Million)
Figure 16 Heptalysis Analysis: Global Irritable Bowel Syndrome with Constipation Drugs Market
Figure 17 Five Whys Analysis
Figure 18 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Drug Type, 2021 Vs 2030, %
Figure 19 Global Irritable Bowel Syndrome with Constipation Drugs Market, By Prescription type, 2021 Vs 2030, %
Figure 20 U.S. Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 21 Canada Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 22 Rest of North America Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 23 UK Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 24 Germany Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 25 Spain Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 26 Italy Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 27 France Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 28 Rest of Europe Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 29 China Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 30 Japan Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 31 India Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 32 Australia Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 33 South Korea Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 34 Rest of Asia Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 35 Brazil Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 36 Mexico Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 37 Rest of Latin America Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 38 GCC Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 39 Africa Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
Figure 40 Rest of Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 2 Global Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 3 North America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 4 North America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 5 U.S. Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 6 U.S. Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 7 Canada Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 8 Canada Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 9 Rest of North America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 10 Rest of North America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 11 UK and European Union Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 12 UK and European Union Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 13 UK Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 14 UK Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 15 Germany Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 16 Germany Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 17 Spain Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 18 Spain Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 19 Italy Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 20 Italy Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 21 France Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 22 France Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 23 Rest of Europe Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 24 Rest of Europe Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 25 Asia Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 26 Asia Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 27 China Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 28 China Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 29 Japan Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 30 Japan Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 31 India Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 32 India Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 33 Australia Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 34 Australia Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 35 South Korea Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 36 South Korea Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 37 Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 38 Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 39 Brazil Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 40 Brazil Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 41 Mexico Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 42 Mexico Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 43 Rest of Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 44 Rest of Latin America Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 45 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 46 Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 47 GCC Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 48 GCC Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 49 Africa Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 50 Africa Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)
Table 51 Rest of Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Drug Type, 2020-2030, USD (Million)
Table 52 Rest of Middle East and Africa Irritable Bowel Syndrome with Constipation Drugs Market By Prescription type, 2020-2030, USD (Million)